News
Amid Boston Overdose Crisis, a Pair of Harvard Students Are Bringing Narcan to the Red Line
News
At First Cambridge City Council Election Forum, Candidates Clash Over Building Emissions
News
Harvard’s Updated Sustainability Plan Garners Optimistic Responses from Student Climate Activists
News
‘Sunroof’ Singer Nicky Youre Lights Up Harvard Yard at Crimson Jam
News
‘The Architect of the Whole Plan’: Harvard Law Graduate Ken Chesebro’s Path to Jan. 6
Baby.The very laughable comedy "Baby" began a short run of one week last night at the Boston Museum.
Mankind."Mankind" was performed at the Boston Theatre last night. The play is a realistic domestic drama, with riots and mobs, and naturally excites a good deal of applause.
Railroad of Love.Daly's Company played in "The Railroad of Love" at the Hollis Street Theatre last night, and tonight they will play in "As You Like It." Miss Ada Rehan's "Rosalind" is a very creditable piece of acting; in New York it received a great deal of praise. The season will end this week on Friday with a performance of "A Night Off," as the company sails for Europe on Saturday.
Jim the Penman."Jim the Penman" received a hearty welcome last night at the Tremont Theatre, and was as great a success as it has been on previous presentations. As is well known the play is rather emotional; it gives Mr. Palmer's Madison Square Theatre Company an excellent opportunity to display its various talents. Mrs. Agnes Booth once more played "Nina," and Mr. Robertson "James Ralston."
Iolanthe."Iolanthe" is now running through its last week at the Globe Theatre. Last night was a benefit night, and the "Rose of Auvergne" was added to the bill. Miss Marie Jansen, as usual, received a large share of the applause-her rendering of the songs, "Be Good," and "Listen to the Tale of Woe," being exceptionally fine. Miss Esther Palliser acquitted herself in a very creditable manner, giving assurance that her testimonial tomorrow, at which she will play "Marguerite," will be a great success.
Want to keep up with breaking news? Subscribe to our email newsletter.